Where does Neutron Therapeutics LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Neutron Therapeutics LLC ranks #29,584 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Neutron Therapeutics LLC hold?

Neutron Therapeutics LLC holds 9 US utility patents granted between 2018 and 2025, spanning 9 technology areas.

What is Neutron Therapeutics LLC's Innovation Score?

Neutron Therapeutics LLC has an Innovation Score of 42.4 out of 100 (top 31% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Neutron Therapeutics LLC's patent grant rate increasing or decreasing?

Neutron Therapeutics LLC's recent grant velocity is +67% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Neutron Therapeutics LLC's patents?

Neutron Therapeutics LLC's patents average 17.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Neutron Therapeutics LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Neutron Therapeutics LLC

Q: What technology areas does Neutron Therapeutics LLC focus on?

Neutron Therapeutics LLC's top technology area is H05H (Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams) with 8 patents. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H05H (Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neutron ranks #29,584 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 9 technology areas.

#29,584
of 49,997 US assignees by volume: Top 31%
by Innovation Score (42.4/100): 17.6
avg claims per patent: +67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29584 · US Corporation #29,584 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,584/49,997
PHOTO-FINISH Neuren Pharmaceuticals
CPC-NARROW H05H · 9 areas
INNOV-PAR 42.4/100
CLAIMS-RICH 17.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Neuren Pharmaceuticals Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Neutron Therapeutics · this assignee

42
3D Lighting… · lowest

7

What this shows Neutron's Innovation Score is 42.4/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Neutron's grants concentrate

Neutron Therapeutics LLC is a focused PatentsView assignee: 9 CPC subclasses with 88.9% of grants classified under H05H (Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2019. By volume, Neutron sits between Neuren Pharmaceuticals Limited and NewSight Reality, Inc..

Neutron's three-year grant acceleration

Neutron Therapeutics LLC shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Neuren Pharmaceut…

9
Neurolutions

9
Neurovision Imagi…

9
Neurocentria

9
New Ideas Manufac…

9
New Standards Man…

9
Newmarket Pharmac…

9
Newsight Reality

9
Neutron Therapeut… ◀

9

What this shows Neutron holds 9 patents at rank #29,597, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neutron

By rank, the assignees closest to #29,597 in granted patent volume.

Leaders in H05H (Plasma Technique)

Other assignees with the most granted patents in Neutron's primary technology class.

Neutron's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Neutron Therapeutics LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	22.2%
2019	1	11.1%
2021	1	11.1%
2023	2	22.2%
2024	2	22.2%
2025partial year	1	11.1%

Which technologies does Neutron Therapeutics LLC patent most?

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 8

G21G - Conversion OF Chemical ELEMENTS; Radioactive Sources 5

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 5

G21K - Techniques FOR Handling Particles OR Ionising Radiation NOT Otherwise Provided FOR; Irradiation DEVICES; Gamma RAY OR X-ray Microscopes 3

C30B - Single-crystal Growth ; Unidirectional Solidification OF Eutectic Material OR Unidirectional Demixing OF Eutectoid MATERIAL; Refining BY Zone-melting OF Material ; Production OF A Homogeneous Polycrystalline Material With Defined Structure ; Single Crystals OR Homogeneous Polycrystalline Material WI 1

H01J - Electric Discharge Tubes OR Discharge Lamps 1

H01C - Resistors 1

H02H - Emergency Protective Circuit Arrangements 1

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#29,584

of 49,997 tracked assignees

Innovation Score

42.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Neutron Therapeutics LLC's patent record in context - here's where to go next.

Neutron Therapeutics LLC's lead technology class is H05H (Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams), 88.9% of its portfolio - see every assignee active in that class. Explore H05H
Ranked #29,584 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Neutron Therapeutics LLC against Neuren Pharmaceuticals Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.